AXA SA (CS.PA) Fundamental Analysis & Valuation

EPA:CS • FR0000120628

Current stock price

42.61 EUR
+0.47 (+1.12%)
Last:

This CS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year CS was profitable.
  • CS had a positive operating cash flow in the past year.
  • Each year in the past 5 years CS has been profitable.
  • In the past 5 years CS always reported a positive cash flow from operatings.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • With a Return On Assets value of 1.51%, CS perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
  • CS has a Return On Equity of 20.40%. This is in the better half of the industry: CS outperforms 75.00% of its industry peers.
  • CS's Return On Invested Capital of 1.28% is fine compared to the rest of the industry. CS outperforms 66.67% of its industry peers.
  • CS had an Average Return On Invested Capital over the past 3 years of 1.22%. This is in line with the industry average of 2.76%.
  • The last Return On Invested Capital (1.28%) for CS is above the 3 year average (1.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.51%
ROE 20.4%
ROIC 1.28%
ROA(3y)1.26%
ROA(5y)1.14%
ROE(3y)16.64%
ROE(5y)14.8%
ROIC(3y)1.22%
ROIC(5y)1.19%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • CS has a better Profit Margin (10.48%) than 62.50% of its industry peers.
  • CS's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 11.51%, CS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.51%
PM (TTM) 10.48%
GM N/A
OM growth 3Y3.64%
OM growth 5Y14.49%
PM growth 3Y19.31%
PM growth 5Y31.84%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

6

2. CS.PA Health Analysis

2.1 Basic Checks

  • CS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CS has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CS has been reduced compared to 5 years ago.
  • CS has a better debt/assets ratio than last year.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B

2.2 Solvency

  • CS has an Altman-Z score of 0.38. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
  • CS's Altman-Z score of 0.38 is amongst the best of the industry. CS outperforms 87.50% of its industry peers.
  • CS has a debt to FCF ratio of 1.22. This is a very positive value and a sign of high solvency as it would only need 1.22 years to pay back of all of its debts.
  • The Debt to FCF ratio of CS (1.22) is better than 75.00% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that CS is somewhat dependend on debt financing.
  • CS has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
  • Although CS's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 1.22
Altman-Z 0.38
ROIC/WACC0.14
WACC9.5%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.86 indicates that CS may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.86, CS belongs to the top of the industry, outperforming 85.42% of the companies in the same industry.
  • CS has a Quick Ratio of 0.86. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 0.86, CS belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

4

3. CS.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.52% over the past year.
  • CS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.68% yearly.
  • Looking at the last year, CS shows a small growth in Revenue. The Revenue has grown by 5.76% in the last year.
  • The Revenue has been decreasing by -4.15% on average over the past years.
EPS 1Y (TTM)7.52%
EPS 3Y7.81%
EPS 5Y17.68%
EPS Q2Q%6.4%
Revenue 1Y (TTM)5.76%
Revenue growth 3Y-4.44%
Revenue growth 5Y-4.15%
Sales Q2Q%17.13%

3.2 Future

  • CS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.68% yearly.
  • CS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.16% yearly.
EPS Next Y11.01%
EPS Next 2Y9.18%
EPS Next 3Y8.36%
EPS Next 5Y6.68%
Revenue Next Year4.11%
Revenue Next 2Y5.62%
Revenue Next 3Y3.51%
Revenue Next 5Y8.16%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

6

4. CS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.04, which indicates a very decent valuation of CS.
  • 70.83% of the companies in the same industry are more expensive than CS, based on the Price/Earnings ratio.
  • CS is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 9.94 indicates a reasonable valuation of CS.
  • 77.08% of the companies in the same industry are more expensive than CS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.20, CS is valued rather cheaply.
Industry RankSector Rank
PE 11.04
Fwd PE 9.94
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CS is cheaper than 85.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.06
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1
PEG (5Y)0.62
EPS Next 2Y9.18%
EPS Next 3Y8.36%

7

5. CS.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.60%, CS is a good candidate for dividend investing.
  • CS's Dividend Yield is a higher than the industry average which is at 4.28.
  • Compared to an average S&P500 Dividend Yield of 1.82, CS pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.6%

5.2 History

  • The dividend of CS is nicely growing with an annual growth rate of 25.07%!
Dividend Growth(5Y)25.07%
Div Incr Years5
Div Non Decr Years5
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • CS pays out 49.13% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP49.13%
EPS Next 2Y9.18%
EPS Next 3Y8.36%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

CS.PA Fundamentals: All Metrics, Ratios and Statistics

AXA SA

EPA:CS (4/16/2026, 1:06:07 PM)

42.61

+0.47 (+1.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-26
Earnings (Next)07-30
Inst Owners38.28%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap89.08B
Revenue(TTM)91.79B
Net Income(TTM)9.62B
Analysts82.67
Price Target46.89 (10.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.6%
Yearly Dividend2.24
Dividend Growth(5Y)25.07%
DP49.13%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.96%
PT rev (3m)2.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.5%
EPS NY rev (3m)0.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.95%
Revenue NY rev (3m)-3.94%
Valuation
Industry RankSector Rank
PE 11.04
Fwd PE 9.94
P/S 0.97
P/FCF 4.06
P/OCF 3.99
P/B 1.89
P/tB 3.57
EV/EBITDA N/A
EPS(TTM)3.86
EY9.06%
EPS(NY)4.28
Fwd EY10.06%
FCF(TTM)10.49
FCFY24.61%
OCF(TTM)10.69
OCFY25.09%
SpS43.9
BVpS22.56
TBVpS11.94
PEG (NY)1
PEG (5Y)0.62
Graham Number44.2675 (3.89%)
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 20.4%
ROCE 1.69%
ROIC 1.28%
ROICexc 1.33%
ROICexgc 1.78%
OM 11.51%
PM (TTM) 10.48%
GM N/A
FCFM 23.89%
ROA(3y)1.26%
ROA(5y)1.14%
ROE(3y)16.64%
ROE(5y)14.8%
ROIC(3y)1.22%
ROIC(5y)1.19%
ROICexc(3y)1.26%
ROICexc(5y)1.24%
ROICexgc(3y)1.66%
ROICexgc(5y)1.61%
ROCE(3y)1.61%
ROCE(5y)1.58%
ROICexgc growth 3Y-0.47%
ROICexgc growth 5Y17.44%
ROICexc growth 3Y-1.21%
ROICexc growth 5Y14.97%
OM growth 3Y3.64%
OM growth 5Y14.49%
PM growth 3Y19.31%
PM growth 5Y31.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 1.22
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.47%
Interest Coverage 2.24
Cash Conversion N/A
Profit Quality 227.84%
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z 0.38
F-Score8
WACC9.5%
ROIC/WACC0.14
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.43%
Profit Quality(3y)144.7%
Profit Quality(5y)135.51%
High Growth Momentum
Growth
EPS 1Y (TTM)7.52%
EPS 3Y7.81%
EPS 5Y17.68%
EPS Q2Q%6.4%
EPS Next Y11.01%
EPS Next 2Y9.18%
EPS Next 3Y8.36%
EPS Next 5Y6.68%
Revenue 1Y (TTM)5.76%
Revenue growth 3Y-4.44%
Revenue growth 5Y-4.15%
Sales Q2Q%17.13%
Revenue Next Year4.11%
Revenue Next 2Y5.62%
Revenue Next 3Y3.51%
Revenue Next 5Y8.16%
EBIT growth 1Y0.54%
EBIT growth 3Y-0.96%
EBIT growth 5Y9.73%
EBIT Next Year14.71%
EBIT Next 3Y8.27%
EBIT Next 5YN/A
FCF growth 1Y82.85%
FCF growth 3Y46.03%
FCF growth 5Y-0.29%
OCF growth 1Y79.3%
OCF growth 3Y44.6%
OCF growth 5Y-0.25%

AXA SA / CS.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AXA SA (CS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CS.PA.


What is the valuation status of AXA SA (CS.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to AXA SA (CS.PA). This can be considered as Undervalued.


Can you provide the profitability details for AXA SA?

AXA SA (CS.PA) has a profitability rating of 6 / 10.


What is the financial health of AXA SA (CS.PA) stock?

The financial health rating of AXA SA (CS.PA) is 6 / 10.


Can you provide the expected EPS growth for CS stock?

The Earnings per Share (EPS) of AXA SA (CS.PA) is expected to grow by 11.01% in the next year.